Incidence and management of hepatic severe veno-occlusive disease in 273 patients in a single centre with defibrotide

Bone Marrow Transplant. 2016 Sep;51(9):1262-4. doi: 10.1038/bmt.2016.99. Epub 2016 Apr 25.

Authors

R R Pol¹, N Russell¹, E Das-Gupta¹, L Watson¹, L Rachael¹, J Byrne¹

Affiliation

¹ BMT Unit, Department of Haematology, Nottingham University Hospitals NHS Trust, Nottingham, UK.

PMID: 27111044
DOI: 10.1038/bmt.2016.99

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Disease Management
Female
Fibrinolytic Agents
Hematologic Neoplasms / complications
Hematologic Neoplasms / therapy
Hematopoietic Stem Cell Transplantation / adverse effects
Hematopoietic Stem Cell Transplantation / mortality
Hepatic Veno-Occlusive Disease / drug therapy*
Hepatic Veno-Occlusive Disease / etiology
Hepatic Veno-Occlusive Disease / mortality
Humans
Incidence
Male
Middle Aged
Polydeoxyribonucleotides / therapeutic use*
Survival Analysis

Substances

Fibrinolytic Agents
Polydeoxyribonucleotides
defibrotide